Teacher Retirement System Of Texas Replimune Group, Inc. Transaction History

Teacher Retirement System Of Texas

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$15.96 - $22.18 $351 - $487	22 Added 0.22%	10,009 $171,000
Q2 2023 Jul 19, 2023	SELL	$15.65 - $24.1 $16,401 - $25,256	-1,048 Reduced 9.5%	9,987 $232,000
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $25,817 - $42,965	1,477 Added 15.45%	11,035 $195,000
Q4 2022 Feb 10, 2023	BUY	$17.09 - $27.91 $163,346 - $266,763	9,558 New	9,558 $260,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.